Dabigatran Impurity 8
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Dabigatran Impurity 8 Product Information
Dabigatran Impurity 8 is listed under Impurity and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Dabigatran. The product is supplied by Clearsynth under CAT No. CS-O-59205.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Dabigatran Impurity 8
CAS No.
429659-01-8
CAT No.
CS-O-59205
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C18H20N4O5
Molecular Weight
372.38
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Dabigatran Impurity 8 is supplied with detailed characterization data compliant with regulatory guideline. Dabigatran Impurity 8 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Dabigatran.
Overview
Useful research chemical for a range of applications.
Synonyms
Dabigatran Impurity 8
Application Notes
Useful research chemical for a range of applications.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.